期刊文献+

食管癌患者血清CEA和TNF-α的水平及意义 被引量:9

Clinical Significance of Serum CEA and TNF-α Levels in Patients with Esophageal Cancer
暂未订购
导出
摘要 目的 :探讨食管癌患者手术切除前后血清CEA和TNF -α的水平变化及意义。方法 :应用放射免疫分析检测 6 8例食管癌患者血清CEA和TNF -α含量 ,术后 2个月和 6个月分别再检测一次 ,并以 32例正常健康人作对照。结果 :食管癌患者在手术切除前血清CEA和TNF -α的水平显著高于正常人组 (P <0 0 5 ) ,2个月后几乎降至正常水平 (P >0 0 5 )。手术切除后 6个月复发者血清CEA和TNF -α持续异常 ,未复发者血清CEA和TNF -α基本正常。结论 :血清CEA和TNF -α的水平与食管癌患者的病情和预后密切相关 ,具有一定的临床应用价值。 Objective To investigate the clinical significance of the operation-related changes of serum CEA and TNF-α levels in patients with esophageal cancer. Methods Serum levels of CEA and TNF-α were measured with RIA in 68 patients with esophageal cancer and 32 controls before operation. Two and six months after operation, the serum levels were again measured. Results The serum CEA and TNF-α levels in patients were significantly higher than those in controls before operation (P<0.05) and returned to almost normal two months after operation (P>0.05). Six months after operation the levels of serum CEA and TNF-α in patients who developed matastasis were abnormally high again while the levels in patients without matastasis remained normal. Conclusion The changes of the levels of serum CEA and TNF-α were closely related to the disease status and was of prognostic value in esophageal cancer.
出处 《放射免疫学杂志》 CAS 2004年第5期350-351,共2页 Journal of Radioimmanology
关键词 血清CEA TNF-Α 患者 食管癌 正常 手术切除 TNF—α 水平 健康人 esophageal neoplasms, carcinoembryonic antigen (CEA), necrosis factor (TNF-α)
  • 相关文献

参考文献6

  • 1Anthony Cerami,张凤蕴.炎性细胞因子[J].国外医学(免疫学分册),1992,15(5):261-263. 被引量:106
  • 2Seynhaeve AL, de Wilh JH, van Tiel ST, et al. Isolated limb perfusion with actinomycin D and TNF - alpha results in improved tumor response in soft tissue sarcoma - bearing rats but is accompanied by sever local toxicity. Bj Cancer. 2002, 86:1174.
  • 3Lans TE, ten Hagen TL, van Horssen R, et al. Improved antitumor response to isolated limb perfusion with tumor necrosis factor after upregulation of endothelial monocyte - activating polypeptide Ⅱ in soft tissue sarcoma. Ann Surg Oncol. 2002, 9:812.
  • 4Tsimberidou AM, Giles FJ. TNF - alpha targeted therapeutic approaches in patients with hematologic malignancies. Exper Rev Anticancer Ther. 2002, 2:277.
  • 5De Wilt JH, Ten Hagen TL, de Boeck G, et al. Tumour necrosis factor - alpha increases melphalan concentration in tumor tissue after isolated limb perfusion. Br J Cancer. 2000, 82:1000.
  • 6Nakamoto T, Inagawa H, Takagi K, et al. Pharmacokinetics of isolated hepatic perfusion with high dose tumor necrosis factor in rat model.Anticancer Res. 2000, 20:619.

共引文献105

同被引文献45

引证文献9

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部